7-116527154-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001753.5(CAV1):c.195+465C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.654 in 202,494 control chromosomes in the GnomAD database, including 44,719 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.65 ( 32735 hom., cov: 31)
Exomes 𝑓: 0.67 ( 11984 hom. )
Consequence
CAV1
NM_001753.5 intron
NM_001753.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.233
Publications
39 publications found
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
- pulmonary arterial hypertensionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- partial lipodystrophy, congenital cataracts, and neurodegeneration syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- pulmonary hypertension, primary, 3Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- congenital generalized lipodystrophy type 3Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Berardinelli-Seip congenital lipodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- amyotrophic lateral sclerosisInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.914 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CAV1 | NM_001753.5 | c.195+465C>T | intron_variant | Intron 2 of 2 | ENST00000341049.7 | NP_001744.2 | ||
| CAV1 | NM_001172895.1 | c.102+465C>T | intron_variant | Intron 2 of 2 | NP_001166366.1 | |||
| CAV1 | NM_001172896.2 | c.102+465C>T | intron_variant | Intron 1 of 1 | NP_001166367.1 | |||
| CAV1 | NM_001172897.2 | c.102+465C>T | intron_variant | Intron 2 of 2 | NP_001166368.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.648 AC: 98430AN: 151896Hom.: 32713 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
98430
AN:
151896
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.673 AC: 33963AN: 50480Hom.: 11984 AF XY: 0.676 AC XY: 17410AN XY: 25762 show subpopulations
GnomAD4 exome
AF:
AC:
33963
AN:
50480
Hom.:
AF XY:
AC XY:
17410
AN XY:
25762
show subpopulations
African (AFR)
AF:
AC:
1026
AN:
2076
American (AMR)
AF:
AC:
2692
AN:
3576
Ashkenazi Jewish (ASJ)
AF:
AC:
696
AN:
1170
East Asian (EAS)
AF:
AC:
2895
AN:
3078
South Asian (SAS)
AF:
AC:
3591
AN:
5526
European-Finnish (FIN)
AF:
AC:
1499
AN:
1900
Middle Eastern (MID)
AF:
AC:
127
AN:
216
European-Non Finnish (NFE)
AF:
AC:
19558
AN:
30132
Other (OTH)
AF:
AC:
1879
AN:
2806
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
491
982
1474
1965
2456
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
230
460
690
920
1150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.648 AC: 98499AN: 152014Hom.: 32735 Cov.: 31 AF XY: 0.656 AC XY: 48761AN XY: 74298 show subpopulations
GnomAD4 genome
AF:
AC:
98499
AN:
152014
Hom.:
Cov.:
31
AF XY:
AC XY:
48761
AN XY:
74298
show subpopulations
African (AFR)
AF:
AC:
21536
AN:
41428
American (AMR)
AF:
AC:
10764
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
AC:
2139
AN:
3470
East Asian (EAS)
AF:
AC:
4845
AN:
5174
South Asian (SAS)
AF:
AC:
3311
AN:
4810
European-Finnish (FIN)
AF:
AC:
8556
AN:
10564
Middle Eastern (MID)
AF:
AC:
158
AN:
294
European-Non Finnish (NFE)
AF:
AC:
45278
AN:
67986
Other (OTH)
AF:
AC:
1362
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1692
3383
5075
6766
8458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
794
1588
2382
3176
3970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2770
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.